Web10 de abr. de 2024 · A conditional recommendation against cefiderocol for the treatment of infections caused by CR-Ab has been conversely stated by the ECCMID, in which the use of ampicillin/sulbactam, polymyxin, or high-dose tigecycline, or a carbapenem combination therapy has been suggested in sulbactam-susceptible CR-Ab HAP/VAP, in sulbactam … Web1 de jun. de 2008 · High-dose ampicillin–sulbactam as an alternative treatment of late onset VAP from multidrug-resistant Acinetobacter baumannii Scand J Infect Dis , 39 ( 2007 ) , pp. 38 - 43 CrossRef View Record in Scopus Google Scholar
Efficacy of sulbactam for the treatment of Acinetobacter …
WebWe did a comprehensive meta-analysis to explore the efficacy of sulbactam for the treatment of Acinetobacter baumannii complex ... 95% CI 1.11-2.48) of A. baumannii … Web21 de fev. de 2014 · Based on the result, the high dose was approved in 2012. While the PK profile for ampicillin/sulbactam in healthy and renally impaired subjects is well known 3–6,12, there is no published account of high dose ampicillin/sulbactam PK in Japanese patients with CAP. litho circuits limited
Treatment of Carbapenem-Resistant Acinetobacter baumannii
WebWe did a comprehensive meta-analysis to explore the efficacy of sulbactam for the treatment of Acinetobacter baumannii complex ... 95% CI 1.11-2.48) of A. baumannii complex infection favored high-dose sulbactam group. In conclusion, our findings suggested that the overall therapy effect of sulbactam was no more superior than … Web8 de jul. de 2009 · The increased incidence of multidrug-resistant (MDR) Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients poses a severe … WebThe aim of this study was to evaluate the efficacy and safety of 2 high-dose treatment regimens of ampicillin-sulbactam (A/S) for MDR Acinetobacter baumannii VAP. We … imsm philippines corporation